Concepedia

Mark J. Mulligan

MJ

Statistics

Publications

190

Citations

23.8K

H-Index

69

Active since

1975

Affiliations

Emory University(Current)

New York University

University of Alabama at Birmingham

HOPE Clinic

National Institute of Allergy and Infectious Diseases

Mark J. Mulligan is an author at Emory University specializing in infectious diseases, immunology, and vaccinology.

ORCID

Publications per year

1975–2025

190

Publications

190

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh, Robert W. Frenck, Ann R. Falsey et al. · New England Journal of Medicine · 2020 · 2.7K citations · Full text

, , +17

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin et al. · Nature · 2020 · 1.6K citations · Full text

, , +17

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

Troy D. Querec, Rama Akondy, Eva K. Lee et al. · Nature Immunology · 2008 · 1.1K citations · Full text

, , +14

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines

Shuzhao Li, Nadine Rouphael, Sai Duraisingham et al. · Nature Immunology · 2013 · 803 citations · Full text

, , +17

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

Jens Wrammert, Dimitrios Koutsonanos, Guimei Li et al. · The Journal of Experimental Medicine · 2011 · 802 citations · Full text

, , +17

1–5 of 190